Literature DB >> 20221684

The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract.

Willem Verpoest1, Sara Seneca, Marjan De Rademaeker, Karen Sermon, Martine De Rycke, Michel De Vos, Patrick Haentjens, Paul Devroey, Ingeborg Liebaers.   

Abstract

PURPOSE: This study aims to analyze the relationship between trinucleotide repeat length and reproductive outcome in a large cohort of DM1 patients undergoing ICSI and PGD.
METHODS: Prospective cohort study. The effect of trinucleotide repeat length on reproductive outcome per patient was analyzed using bivariate analysis (T-test) and multivariate analysis using Kaplan-Meier and Cox regression analysis.
RESULTS: Between 1995 and 2005, 205 cycles of ICSI and PGD were carried out for DM1 in 78 couples. The number of trinucleotide repeats does not have an influence on reproductive outcome when adjusted for age, BMI, basal FSH values, parity, infertility status and male or female affected. Cox regression analysis indicates that cumulative live birth rate is not influenced by the number of trinucleotide repeats. The only factor with a significant effect is age (p < 0.05).
CONCLUSION: There is no evidence of an effect of trinucleotide repeat length on reproductive outcome in patients undergoing ICSI and PGD.

Entities:  

Mesh:

Year:  2010        PMID: 20221684      PMCID: PMC2914592          DOI: 10.1007/s10815-010-9392-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  32 in total

Review 1.  Myotonic dystrophy: emerging mechanisms for DM1 and DM2.

Authors:  Diane H Cho; Stephen J Tapscott
Journal:  Biochim Biophys Acta       Date:  2006-06-20

2.  Effect of timing of oocyte denudation and micro-injection on survival, fertilization and embryo quality after intracytoplasmic sperm injection.

Authors:  H Van de Velde; A De Vos; H Joris; Z P Nagy; A C Van Steirteghem
Journal:  Hum Reprod       Date:  1998-11       Impact factor: 6.918

Review 3.  Clinical and molecular aspects of the myotonic dystrophies: a review.

Authors:  Laura Machuca-Tzili; David Brook; David Hilton-Jones
Journal:  Muscle Nerve       Date:  2005-07       Impact factor: 3.217

4.  Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure.

Authors:  Lisbet Van Landuyt; Anick De Vos; Hubert Joris; Greta Verheyen; Paul Devroey; André Van Steirteghem
Journal:  Fertil Steril       Date:  2005-05       Impact factor: 7.329

5.  Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation?

Authors:  E Feyereisen; A Amar; V Kerbrat; J Steffann; A Munnich; M Vekemans; R Frydman; N Frydman
Journal:  Hum Reprod       Date:  2005-09-30       Impact factor: 6.918

6.  Clinical application of preimplantation diagnosis for myotonic dystrophy.

Authors:  K Sermon; W Lissens; H Joris; S Seneca; S Desmyttere; P Devroey; A Van Steirteghem; I Liebaers
Journal:  Prenat Diagn       Date:  1997-10       Impact factor: 3.050

7.  Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients.

Authors:  K Osmanagaoglu; H Tournaye; M Camus; M Vandervorst; A Van Steirteghem; P Devroey
Journal:  Hum Reprod       Date:  1999-10       Impact factor: 6.918

8.  Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I.

Authors:  Banchhita Sahu; Ozkan Ozturk; Nandita Deo; Karen Fordham; Massimo Ranierri; Paul Serhal
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

9.  Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.

Authors:  C L Winchester; R K Ferrier; A Sermoni; B J Clark; K J Johnson
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

10.  Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection.

Authors:  I Liebaers; K Sermon; C Staessen; H Joris; W Lissens; E Van Assche; P Nagy; M Bonduelle; M Vandervorst; P Devroey; A Van Steirteghem
Journal:  Hum Reprod       Date:  1998-04       Impact factor: 6.918

View more
  4 in total

1.  Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy.

Authors:  Cheonga Yee; Suk-Joo Choi; Soo-Young Oh; Chang-Seok Ki; Cheong-Rae Roh; Jong-Hwa Kim
Journal:  Obstet Gynecol Sci       Date:  2017-07-14

2.  Impact of prematurity and the CTG repeat length on outcomes in congenital myotonic dystrophy.

Authors:  Yu Saito; Kenta Matsumura; Misao Kageyama; Yuichi Kato; Eiji Ohta; Kiyoaki Sumi; Takeshi Futatani; Taketoshi Yoshida
Journal:  BMC Res Notes       Date:  2020-07-23

Review 3.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

4.  Preimplantation Genetic Diagnosis for Myotonic Dystrophy Type 1 and Analysis of the Effect of the Disease on the Reproductive Outcome of the Affected Female Patients.

Authors:  Raquel María Fernández; María Dolores Lozano-Arana; Beatriz Sánchez; Ana Peciña; Juan Carlos García-Lozano; Salud Borrego; Guillermo Antiñolo
Journal:  Biomed Res Int       Date:  2017-11-14       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.